These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11328)

  • 21. The effect of enzyme induction on the stereoselective metabolism of optically pure (-)1R,2R- and (+)1S,2S-dihydroxy-1,2-dihydrobenz-[a]anthracenes to vicinal 1,2-dihydrodiol 3,4-epoxides by rat liver microsomes.
    Chou MW; Chiu PL; Fu PP; Yang SK
    Carcinogenesis; 1983; 4(5):629-38. PubMed ID: 6850995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro and in vivo metabolism of dibenzo-(c,f)-(1,2)diazepine].
    Cappellini L; de Pascale A; Negrini P; Frigerio A; Rossi E; Testoni G
    Boll Chim Farm; 1979 Jun; 118(6):316-31. PubMed ID: 554625
    [No Abstract]   [Full Text] [Related]  

  • 23. The biotransformation of 1-hexadecene to carcinogenic 1,2-epoxyhexadecane by hepatic microsomes.
    Watabe T; Yamada N
    Biochem Pharmacol; 1975 May; 24(9):1051-3. PubMed ID: 1156447
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel stereoselectivity of rat liver cytochrome(s) P450 toward enantiomers of the trans-1,2-dihydrodiol of triphenylene.
    Thakker DR; Boehlert C; Levin W; Ryan DE; Thomas PE; Yagi H; Jerina DM
    Arch Biochem Biophys; 1991 Jul; 288(1):54-63. PubMed ID: 1898024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin K epoxide reductase activity in the metabolism of epoxides.
    Liptay-Reuter I; Dose K; Guenthner T; Wörner W; Oesch F
    Biochem Pharmacol; 1985 Aug; 34(15):2617-20. PubMed ID: 4015704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel metabolic pathways for linoleic and arachidonic acid metabolism.
    Moghaddam M; Motoba K; Borhan B; Pinot F; Hammock BD
    Biochim Biophys Acta; 1996 Aug; 1290(3):327-39. PubMed ID: 8765137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of epinastine, a histamine H1 receptor antagonist, in human liver microsomes in comparison with that of terfenadine.
    Kishimoto W; Hiroi T; Sakai K; Funae Y; Igarashi T
    Res Commun Mol Pathol Pharmacol; 1997 Dec; 98(3):273-92. PubMed ID: 9485522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereochemistry in the oxidative metabolism of styrene by hepatic microsomes.
    Watabe T; Ozawa N; Yoshikawa K
    Biochem Pharmacol; 1981 Jun; 30(12):1695-8. PubMed ID: 7271853
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro metabolism of 4-vinylcyclohexene in rat and mouse liver, lung, and ovary.
    Keller DA; Carpenter SC; Cagen SZ; Reitman FA
    Toxicol Appl Pharmacol; 1997 May; 144(1):36-44. PubMed ID: 9169067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass spectrometric identification of an N-oxide formed by incubation of N,N-dimethyl-5H-dibenzo[a,d]cycloheptene-delta5,gamma-propylamine with rat liver microsomes.
    Belvedere G; Rovei V; Pantarotto C; Frigerio A
    Biomed Mass Spectrom; 1974 Oct; 1(5):329-31. PubMed ID: 4465001
    [No Abstract]   [Full Text] [Related]  

  • 31. Proceedings: Covalent protein binding of norethisterone and norethisterone-4,5-epoxide in liver microsomes.
    Kappus H; Bolt HM
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R73. PubMed ID: 1143488
    [No Abstract]   [Full Text] [Related]  

  • 32. Epoxide hydrolase-dependent metabolism of butadiene monoxide to 3-butene-1,2-diol in mouse, rat, and human liver.
    Krause RJ; Sharer JE; Elfarra AA
    Drug Metab Dispos; 1997 Aug; 25(8):1013-5. PubMed ID: 9280411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hydration of sterically hindered epoxides by epoxide hydrolase of the rat and rabbit.
    Walker CH; Timms CW; Wolf CR; Oesch F
    Biochem Pharmacol; 1986 Feb; 35(3):499-503. PubMed ID: 3947384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic and extrahepatic metabolism, in vitro, of an epoxide (8-(14) C-styrene oxide) in the rabbit.
    James MO; Fouts JR; Bend JR
    Biochem Pharmacol; 1976 Jan; 25(2):187-93. PubMed ID: 4076
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolism of benzo[a]anthracene to its tumorigenic 3,4-dihydrodiol.
    Thakker DR; Levin W; Yagi H; Ryan D; Thomas PE; Karle JM; Lehr RE; Jerina DM; Conney AH
    Mol Pharmacol; 1979 Jan; 15(1):138-53. PubMed ID: 423885
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes.
    Nordqvist M; Thakker DR; Vyas KP; Yagi H; Levin W; Ryan DE; Thomas PE; Conney AH; Jerina DM
    Mol Pharmacol; 1981 Jan; 19(1):168-78. PubMed ID: 7207460
    [No Abstract]   [Full Text] [Related]  

  • 37. Epoxidation of several vitamins K by rat liver microsomes.
    Friedman PA; Smith MW
    Biochem Pharmacol; 1979 Mar; 28(6):937-8. PubMed ID: 454489
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolic activation of the nontricyclic antidepressant trazodone to electrophilic quinone-imine and epoxide intermediates in human liver microsomes and recombinant P4503A4.
    Kalgutkar AS; Henne KR; Lame ME; Vaz AD; Collin C; Soglia JR; Zhao SX; Hop CE
    Chem Biol Interact; 2005 Jun; 155(1-2):10-20. PubMed ID: 15978881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of benzo[a]pyrene: conversion of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides.
    Thakker DR; Yagi H; Lu AY; Levin W; Conney AH
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3381-5. PubMed ID: 1068451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
    Cook CS; Hauswald C; Oppermann JA; Schoenhard GL
    J Pharmacol Exp Ther; 1993 Jul; 266(1):1-7. PubMed ID: 8331551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.